Bryan Chong
Impact in
-
- Cardiovascular Health and Risk Factors
- Epidemiology top 1%
- Acute Ischemic Stroke Management
- Liver Disease Diagnosis and Treatment
- Healthcare Systems and Public Health
Papers in
-
- Cardiovascular Health and Risk Factors 16
- Acute Myocardial Infarction Research 11
- Epidemiology 21
- Liver Disease Diagnosis and Treatment 10
- Healthcare Systems and Public Health 7
- Co-authors
- Nicholas Chew (34 shared papers)Mark Dhinesh Muthiah (18 shared papers)Yip Han Chin (20 shared papers)Gwyneth Kong (25 shared papers)Yan Yee Mark Chan (24 shared papers)Cheng Han Ng (10 shared papers)Roger Foo (13 shared papers)Rachel Sze Jen Goh (7 shared papers)
- Journals
- The Lancet (14 papers)Journal of the American College of Cardiology (10 papers)The Lancet Public Health (9 papers)European Heart Journal (6 papers)Diabetes Obesity and Metabolism (3 papers)
- Partner nations
- SingaporeUnited StatesUnited Kingdom
In The Last Decade
Bryan Chong
81 papers receiving 12.4k citations
Bryan Chong's Hit Papers
Peers
Comparison fields: 5 of 183
- Cardiology and Cardiovascular Medicine 1.6k
- Epidemiology 1.9k
- Endocrinology, Diabetes and Metabolism 910
- Oncology 1.2k
- Health, Toxicology and Mutagenesis 734
Countries citing papers authored by Bryan Chong
This map shows the geographic impact of Bryan Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Chong more than expected).
Fields of papers citing papers by Bryan Chong
This network shows the impact of papers produced by Bryan Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Chong. The network helps show where Bryan Chong may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Chong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 3041 |
| 2 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1712 |
| 3 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1679 |
| 4 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 948 |
| 5 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 702 |
| 6 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 675 |
| 7 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 657 |
| 8 | Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 463 |
| 9 | Global burden of cardiovascular diseases: projections from 2025 to 2050 Hit paper breakdown → | 2024 | 359 |
| 10 | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 318 |
| 11 | Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 222 |
| 12 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 210 |
| 13 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 191 |
| 14 | National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050 Hit paper breakdown → | 2024 | 176 |
| 15 | Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 150 |
| 16 | The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019 Hit paper breakdown → | 2023 | 124 |
| 17 | Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach Hit paper breakdown → | 2024 | 92 |
| 18 | 2022 | 83 | |
| 19 | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 70 |
| 20 | Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 65 |
About Bryan Chong
Bryan Chong is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology, Demography, Endocrinology, Diabetes and Metabolism and Health Information Management, having authored 95 papers that have together received 12.9k indexed citations. Recurring topics across this work include Cardiovascular Health and Risk Factors (16 papers), Acute Myocardial Infarction Research (11 papers), Insurance, Mortality, Demography, Risk Management (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Healthcare Systems and Public Health (7 papers), Global Health and Epidemiology (6 papers) and Smoking Behavior and Cessation (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.6k citations), Epidemiology (1.9k citations), Endocrinology, Diabetes and Metabolism (910 citations), Oncology (1.2k citations) and Health, Toxicology and Mutagenesis (734 citations). Bryan Chong has collaborated with scholars based in Singapore, United States and United Kingdom. Frequent co-authors include Nicholas Chew, Mark Dhinesh Muthiah, Yip Han Chin, Gwyneth Kong, Yan Yee Mark Chan, Cheng Han Ng, Roger Foo, Rachel Sze Jen Goh, Chin Meng Khoo and Poay Huan Loh. Their work appears in journals such as The Lancet, Journal of the American College of Cardiology, The Lancet Public Health, European Heart Journal and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.